JoVE   
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Biology

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Neuroscience

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Immunology and Infection

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Clinical and Translational Medicine

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Bioengineering

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Applied Physics

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Chemistry

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Behavior

  
You do not have subscription access to articles in this section. Learn more about access.

  JoVE Environment

|   

JoVE Science Education

General Laboratory Techniques

You do not have subscription access to videos in this collection. Learn more about access.

Basic Methods in Cellular and Molecular Biology

You do not have subscription access to videos in this collection. Learn more about access.

Model Organisms I

You do not have subscription access to videos in this collection. Learn more about access.

Model Organisms II

You do not have subscription access to videos in this collection. Learn more about access.

Essentials of
Neuroscience

You do not have subscription access to videos in this collection. Learn more about access.

 JoVE Clinical and Translational Medicine

Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery

1, 1, 2, 2, 2, 1, 1

1Cork Cancer Research Centre, Mercy University Hospital and Leslie C. Quick Jnr. Laboratory, University College Cork, 2Department of Computer Science, University College Cork

Article
    Downloads Comments Metrics

    You must be subscribed to JoVE to access this content.

    This article is a part of   JoVE Clinical and Translational Medicine. If you think this article would be useful for your research, please recommend JoVE to your institution's librarian.

    Recommend JoVE to Your Librarian

    Current Access Through Your IP Address

    You do not have access to any JoVE content through your current IP address.

    IP: 54.198.94.76, User IP: 54.198.94.76, User IP Hex: 918969932

    Current Access Through Your Registered Email Address

    You aren't signed into JoVE. If your institution subscribes to JoVE, please or create an account with your institutional email address to access this content.

     

    Summary

    This article describes the culture of patient tissue slices for gene delivery studies and subsequent analysis of gene expression using IVIS bioluminescence imaging.

    Date Published: 12/20/2010, Issue 46; doi: 10.3791/2378

    Cite this Article

    Rajendran, S., Salwa, S., Gao, X., Tabirca, S., O'Hanlon, D., O'Sullivan, G. C., et al. Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery. J. Vis. Exp. (46), e2378, doi:10.3791/2378 (2010).

    Abstract

    This video describes the use of patient tissue as an ex vivo model for the study of gene delivery. Fresh patient tissue obtained at the time of surgery is sliced and maintained in culture. The ex vivo model system allows for the physical delivery of genes into intact patient tissue and gene expression is analysed by bioluminescence imaging using the IVIS detection system. The bioluminescent detection system demonstrates rapid and accurate quantification of gene expression within individual slices without the need for tissue sacrifice. This slice tissue culture system may be used in a variety of tissue types including normal and malignant tissue and allows us to study the effects of the heterogeneous nature of intact tissue and the high degree of variability between individual patients. This model system could be used in certain situations as an alternative to animal models and as a complementary preclinical mode prior to entering clinical trial.

    Protocol

    Preparation of Media and Reagents

    1. Antibiotic Solution
      Phosphate buffered saline (PBS) with 200 U/ml penicillin, 200 μg/ml streptomycin, 5 μg/ml fungizone
    2. Collection and Treatment medium
      Dulbecco's modified eagle medium (DMEM) with 200 U/ml penicillin, 200 μg/ml streptomycin, 5 μg/ml fungizone
    3. Culture medium
      Collection medium containing 10% heat-inactivated fetal bovine serum

    I. Tissue collection and storage

    Approval for patient tissue collection was obtained from the Clinical Research Ethics Committee of the Cork Teaching Hospitals and informed consent was obtained from the patients the day before surgery. Liver tissue was obtained from patients undergoing partial hepatectomy for malignant disease.

    1. Fresh patient tissue is obtained at the time of surgical resection.
    2. Tissue is stored in collection media at 4°C (Tissue may be stored refrigerated for up to 12 h without significant loss of viability, however immediate processing is recommended).

    II. Tissue slice preparation and culture

    Slicing was performed using a vibratome (Leica, Germany). The tissue slicing system was used according to the manufacturer's instructions. Tissue slice preparation was performed under a sterile hood using instruments cleaned with 70% 2-propanol. Slice thickness is set at 2000 microns and cut using a reciprocating blade at 22-26 rpm.

    1. Tissue is washed in antibiotic solution three times.
    2. Tissue is attached to mounting stage using non-toxic adhesive (Dermabond).
    3. Slice thickness is set and slicing is achieved at 22-26 rpm.
    4. Slices are maintained in culture medium in 6-well culture dishes (one slice per well) at 37°C with 5% CO2 in a humidified environment.

    III. Gene delivery to tissue slices

    1. Slices are pre-incubated at 37°C for 2 h prior to treatment.
    2. Culture medium is replaced with treatment medium.
    3. Slices are directly injected with viral vector (25 μl of viral particles Ad5.CMVluc [1x109]). Alternatively, particles may be added to the medium, for passive infusion.
    4. After two hours of incubation, serum is added to medium.

    IV. Analysis of gene expression by bioluminescent analysis

    1. Slices are injected with 100 μl of luciferin substrate (3 mg/ml).
    2. 6-well culture dish is placed on stage and incubated for 10 min.
    3. Slices are imaged for 5 min at high sensitivity (Figure 1).

    V. Representative Results

    Figure 1
    Figure 1. Bioluminescent imaging of patient liver slices using IVIS detection system.

    Subscription Required. Please recommend JoVE to your librarian.

    Discussion

    We describe an ex vivo patient tissue culture method and bioluminescent detection system for the assessment of gene delivery within non-fixed human tissue. The method offers a simple and reproducible way of culturing tissue slices. It has significant potential as it allows the study of gene delivery into intact human tissue, the analysis of gene delivery into a variety of human tissue including malignant tissue and can provide important information concerning the effects of the high degree of variability between individual patients with respect to gene uptake. Different cancer types may have varying influences on the efficacy of the different stages of successful transgene expression in cells, involving DNA uptake and subsequent transcription and translation. These steps are outlined in the video animation, using viral vector as an example. The bioluminescent detection system demonstrates rapid and accurate quantification of gene expression within individual slices without the need for tissue sacrifice. For replication incompetent vectors, such as employed in this study, luminescence is directly related to gene expression by cells.

    This model system will provide valuable information regarding gene delivery to patient tissue prior to entering clinical trial.

    Subscription Required. Please recommend JoVE to your librarian.

    Disclosures

    No conflicts of interest declared.

    Acknowledgements

    This work was funded through the Cork South Infirmary Victoria University Hospital Breast fund, the Irish Cancer Society (CRI07TAN) and the Cork Cancer Research Centre. Replication incompetent recombinant Adenovirus 5 particles under the transcriptional control of the CMV promoter was a kind gift from Prof. Andrew Baker, University of Glasgow.

    Materials

    Name Company Catalog Number Comments
    DMEM Sigma-Aldrich D6429
    PBS Sigma-Aldrich D8537
    Firefly Luciferin Biosynth International, Inc
    Dermabond Johnson & Johnson
    Vibrotome Leica Microsystems VT 1000 A

    References

    1. van de Bovenkamp, M., Groothuis, G.M., Draaisma, A.L., Merema, M.T., Bezuijen, J.I., van Gils, M.J., et al. Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicol Sci. 85(1):632-8 (2005).
    2. Speirs, V., Green, A.R., Walton, D.S., Kerin, M.J., Fox, J.N., Carleton, P.J., et al. Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer. 78(11):1421-9 (1998).
    3. Kirby, T.O., Rivera, A., Rein, D., Wang, M., Ulasov, I., Breidenbach, M., et al. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Clin Cancer Res. 10(24):8697-703 (2004).
    4. Josserand, V., Texier-Nogues, I., Huber, P., Favrot, M.C., Coll, J.L. Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice. Gene Ther. 14(22):1587-93 (2007).

    Comments

    0 Comments

    Post a Question / Comment / Request

    You must be signed in to post a comment. Please or create an account.

    Metrics

    Waiting
    simple hit counter